Products - Biliary tract cancers | Topic | NICE

Showing 1 product

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more lines of systemic treatment [ID6388]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC